These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3859744)

  • 1. Acute and chronic hepatitis in childhood leukemia: a multicentric study from the Italian Pediatric Cooperative Group for Therapy of Acute Leukemia (AIL-AIEOP).
    Locasciulli A; Alberti A; Rossetti F; Santamaria M; Santoro N; Madon E; Miniero R; Lo Curto M; Tamaro P; Paolucci P
    Med Pediatr Oncol; 1985; 13(4):203-6. PubMed ID: 3859744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic liver disease in children with leukemia in long-term remission.
    Locasciulli A; Vergani GM; Uderzo C; Jean G; Cattaneo M; Vergani D; Portmann B; Masera G
    Cancer; 1983 Sep; 52(6):1080-7. PubMed ID: 6576846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic hepatitis in childhood: the spectrum of the disease.
    Bortolotti F; Calzia R; Vegnente A; Cadrobbi P; Rugge M; Armigliato M; Marazzi MG; Iorio R; Crivellaro C; Piscopo R
    Gut; 1988 May; 29(5):659-64. PubMed ID: 3396953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus markers in children with acute leukemia: the effect of chemotherapy.
    Locasciulli A; Santamaria M; Masera G; Schiavon E; Alberti A; Realdi G
    J Med Virol; 1985 Jan; 15(1):29-33. PubMed ID: 3855443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased risk of chronic hepatitis in children with cancer.
    Sevinir B; Meral A; Günay U; Ozkan T; Ozuysal S; Sinirtas M
    Med Pediatr Oncol; 2003 Feb; 40(2):104-10. PubMed ID: 12461794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histological evidence of hepatitis-B-virus infection with negative serology in children with acute leukaemia who develop chronic liver disease.
    Vergani D; Locasciulli A; Masera G; Alberti A; Moroni G; Tee DE; Portmann B; Mieli Vergani G; Eddleston AL
    Lancet; 1982 Feb; 1(8268):361-4. PubMed ID: 6120349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic antiviral therapy in allogeneic hematopoietic stem cell transplantation in hepatitis B virus patients.
    Liao YP; Jiang JL; Zou WY; Xu DR; Li J
    World J Gastroenterol; 2015 Apr; 21(14):4284-92. PubMed ID: 25892880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low incidence of hepatitis B virus reactivation during chemotherapy among diffuse large B-cell lymphoma patients who are HBsAg-negative/ HBcAb-positive: a multicenter retrospective study.
    Ji D; Cao J; Hong X; Li J; Wang J; Chen F; Wang C; Zou S
    Eur J Haematol; 2010 Sep; 85(3):243-50. PubMed ID: 20491883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lamivudine therapy in acute leukemia patients who are hepatitis B surface antigen carriers.
    Yilmaz M; Dagdas S; Güler N; Aki SZ; Aköz AG; Özet G; Ayli M; Saritas U
    Hematology; 2003 Dec; 8(6):393-6. PubMed ID: 14668034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal radioimmunoassay for hepatitis B surface antigen in sera of children with acute leukemia.
    Locasciulli A; Pontisso P; Schiavon E; Sala E; Chemello L; Masera G; Alberti A
    J Med Virol; 1986 Oct; 20(2):101-4. PubMed ID: 3534139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of hepatitis B infection in pediatric acute lymphoblastic leukemia in a tertiary care center from South India.
    Guruprasad B; Kavitha S; Aruna Kumari BS; Vijaykumar BR; Sumati BG; Mahua S; Appaji L; Jayshree RS
    Pediatr Blood Cancer; 2014 Sep; 61(9):1616-9. PubMed ID: 24798418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute hepatic toxicity during cyclic chemotherapy in non Hodgkin's lymphoma.
    Faggioli P; De Paschale M; Tocci A; Luoni M; Fava S; De Paoli A; Tosi A; Cassi E
    Haematologica; 1997; 82(1):38-42. PubMed ID: 9107080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No adverse prognostic influence of hepatitis B virus infection in acute childhood lymphoblastic leukemia.
    Lampert F; Willems WR; Bertram U; Berthold F
    Blut; 1987 Aug; 55(2):115-20. PubMed ID: 3475137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of hepatitis B and C and relationship to liver damage in HIV infected patients attending Joint Clinical Research Centre Clinic (JCRC), Kampala, Uganda.
    Baseke J; Musenero M; Mayanja-Kizza H
    Afr Health Sci; 2015 Jun; 15(2):322-7. PubMed ID: 26124775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma.
    Chu CM
    J Gastroenterol Hepatol; 2000 May; 15 Suppl():E25-30. PubMed ID: 10921378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus and primary hepatocellular carcinoma: family studies in Korea.
    Hann HW; Kim CY; London WT; Whitford P; Blumberg BS
    Int J Cancer; 1982 Jul; 30(1):47-51. PubMed ID: 6288579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus (HBV) infection and liver disease after allogeneic bone marrow transplantation: a report of 30 cases.
    Locasciulli A; Bacigalupo A; Van Lint MT; Chemello L; Pontisso P; Occhini D; Uderzo C; Shulman HM; Portmann B; Marmont AM
    Bone Marrow Transplant; 1990 Jul; 6(1):25-9. PubMed ID: 2390630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages.
    Whittle HC; Maine N; Pilkington J; Mendy M; Fortuin M; Bunn J; Allison L; Howard C; Hall A
    Lancet; 1995 Apr; 345(8957):1089-92. PubMed ID: 7715343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different mechanisms responsible for in vitro cell-mediated cytotoxicity to autologous hepatocytes in children with autoimmune and HBsAg-positive chronic liver disease.
    Mondelli M; Mieli-Vergani G; Bortolotti F; Cadrobbi P; Portmann B; Alberti A; Realdi G; Eddleston AL; Mowat AP
    J Pediatr; 1985 Jun; 106(6):899-906. PubMed ID: 3998945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.